Furthermore, it was demonstrated in 236 PCa patients that HER2 over expression is associated with a low expression of the tumor suppressor gen PTEN (phosphatase and tensin homologue) and reduced the cancer-specific survival [55]. This evidence concerns the gene PTEN and posterior cortical atrophy.